Table 1. Baseline characteristics of patients with pancreatic adenocarcinoma (N=95).
| Stage | I (Ia+Ib) | II (IIa+IIb) | III | IV | ||||
|---|---|---|---|---|---|---|---|---|
| N | 11 | 29 | 13 | 42 | ||||
| Age (mean) (SD) | 70 | (10.81) | 67 | (8.21) | 65 | (8.25) | 65 | (9.21) |
| Sex (men:women) | 6:5 | 19:10 | 10:3 | 22:20 | ||||
| ASA 1 (n) (%) | 4 | 36% | 14 | 48% | 8 | 62% | 0 | 0% |
| ASA 2 (n) (%) | 4 | 36% | 11 | 38% | 3 | 23% | 18 | 43% |
| ASA 3 (n) (%) | 3 | 27% | 4 | 14% | 2 | 15% | 12 | 29% |
| Intendent curative surgery (n) (%) | 5 | 45% | 24 | 83% | 4 | 31% | 1 | 2% |
| Preoperative chemotherapy (n) (%) | - | - | 3 | 10% | - | - | - | - |
| Palliative chemotherapy (n) (%) | 3 | 27% | 9 | 31% | 10 | 77% | 27 | 64% |
SD: Standard deviation
ASA: American Society of Anesthesiologists score.
Note: Stage is in accordance with The American Joint Committee on Cancer (AJCC) stage classification.